Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Strides Pharma Science Limited (NSE: STAR), ISIN INE939A01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
STAR last traded at ₹1225.35 (+0.81%), with a 52-week range of ₹769.60 to ₹1260.10 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 27.91%, FIIs 28.39%, DIIs 15.41%, mutual funds 8.73%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.